BCL2L1 and lung carcinoma: To validate the hypothesis, we adopted luciferase reporter plasmid assay by inducing mutation in the 3′-UTR region of BCL2L1, and the let-7a-5p mimics or inhibitors were co-transfected into the mutant or wild-type A549 lung cancer cells.